Cargando…

Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model

Multiple sclerosis (MS) is a chronic demyelinating disease with prominent axon dysfunction. Our previous studies in an MS mouse model, experimental autoimmune encephalomyelitis (EAE), demonstrated that major histocompatibility complex Class II constructs can reverse clinical signs of EAE. These cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zerimech, Sarah, Nguyen, Hung, Vandenbark, Arthur A., Offner, Halina, Baltan, Selva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627517/ https://www.ncbi.nlm.nih.gov/pubmed/37933270 http://dx.doi.org/10.3389/fmmed.2023.1237078

Ejemplares similares

Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE
por: Seifert, Hilary A., et al.
Publicado: (2019)

Casein Kinase 2 Signaling in White Matter Stroke
por: Nguyen, Hung, et al.
Publicado: (2022)

Sex-dependent treatment of chronic EAE with partial MHC class II constructs
por: Benedek, Gil, et al.
Publicado: (2017)

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
por: Vandenbark, Arthur A., et al.
Publicado: (2019)

RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
por: Sinha, Sushmita, et al.
Publicado: (2011)

Identification of miRNAs That Mediate Protective Functions of Anti-Cancer Drugs During White Matter Ischemic Injury
por: Baltan, Selva, et al.
Publicado: (2021)

Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
por: Matejuk, Agata, et al.
Publicado: (2021)

Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020)

Microglia and astrocyte involvement in neurodegeneration and brain cancer
por: Vandenbark, Arthur A., et al.
Publicado: (2021)

Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
por: Bodhankar, Sheetal, et al.
Publicado: (2014)

Disturbed Presynaptic Ca(2+) Signaling in Photoreceptors in the EAE Mouse Model of Multiple Sclerosis
por: Mukherjee, Amrita, et al.
Publicado: (2020)

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis
por: Oveland, Eystein, et al.
Publicado: (2021)

Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis
por: Ravelli, Katherine G., et al.
Publicado: (2019)

Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
por: Hoffman, Kristina, et al.
Publicado: (2023)

Novel Humanized Recombinant T Cell Receptor Ligands Protect the Female Brain After Experimental Stroke
por: Pan, Jie, et al.
Publicado: (2014)

PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
por: Bodhankar, Sheetal, et al.
Publicado: (2013)

Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice
por: Choi, Bo Young, et al.
Publicado: (2015)

MANF Is Neuroprotective in Early Stages of EAE, and Elevated in Spinal White Matter by Treatment With Dexamethasone
por: Nam, Jinhan, et al.
Publicado: (2021)

Effects of perinatal exposure to bisphenol A or S in EAE model of multiple sclerosis
por: Bonaldo, Brigitta, et al.
Publicado: (2023)

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions
por: Orefice, Nicola S, et al.
Publicado: (2020)

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015)

Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review
por: Schmitz, Katja, et al.
Publicado: (2017)

Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis
por: Ng, Xiulin, et al.
Publicado: (2019)

Diffusion Kurtosis Imaging maps neural damage in the EAE model of multiple sclerosis
por: Chuhutin, Andrey, et al.
Publicado: (2020)

Antigen B modulates anti‐inflammatory cytokines in the EAE model of multiple sclerosis
por: Mariki, Aliakbar, et al.
Publicado: (2022)

Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS
por: Dou, Mengmeng, et al.
Publicado: (2021)

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study
por: Yadav, Vijayshree, et al.
Publicado: (2012)

Major histocompatibility complex Class II-based therapy for stroke
por: Gonzales-Portillo, Bella M., et al.
Publicado: (2021)

Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis
por: Casiraghi, Costanza, et al.
Publicado: (2012)

PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis
por: Ghareghani, Majid, et al.
Publicado: (2022)

Gray matter integrity predicts white matter network reorganization in multiple sclerosis
por: Radetz, Angela, et al.
Publicado: (2019)

Longitudinal analysis of white matter and cortical lesions in multiple sclerosis
por: Fartaria, Mário João, et al.
Publicado: (2019)

Mapping the relationship of white matter lesions to depression in multiple sclerosis
por: Baller, Erica B., et al.
Publicado: (2023)

Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions
por: Gillen, Kelly M., et al.
Publicado: (2018)

Spleen participation in partial MHC class II construct neuroprotection in stroke
por: Brown, John, et al.
Publicado: (2020)

Correlation between white matter damage and gray matter lesions in multiple sclerosis patients
por: Han, Xue-mei, et al.
Publicado: (2017)

Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis
por: Dal Monte, Massimo, et al.
Publicado: (2018)

Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis
por: Hamilton, A. Max, et al.
Publicado: (2019)

Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis
por: Wang, Xiaofang, et al.
Publicado: (2014)

Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models
por: Khan, Nemat, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q1mp8ob369imt5hnifsqnks25q